1. Johns Hopkins Coronavirus Resource Center. COVID-19 Map - Johns Hopkins Coronavirus Resource Center. Johns Hopkins Coronavirus Resource Center. 2020. https://coronavirus.jhu.edu/map.html. Accessed 23 Dec 2020.
2. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA - Journal of the American Medical Association. 2020;324:782–93. doi:10.1001/jama.2020.12839.
3. Suleyman G, Fadel RA, Malette KM, Hammond C, Abdulla H, Entz A, et al. Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit. JAMA network open. 2020;3:e2012270. doi:10.1001/jamanetworkopen.2020.12270.
4. Martín-Loeches I, Sanchez-Corral A, Diaz E, Granada RM, Zaragoza R, Villavicencio C, et al. Community-acquired respiratory coinfection in critically III patients with pandemic 2009 influenza A(H1N1) virus. Chest. 2011;139:555–62. doi:10.1378/chest.10-1396.
5. Sepulveda J, Westblade LF, Whittier S, Satlin MJ, Greendyke WG, Aaron JG, et al. Bacteremia and blood culture utilization during covid-19 surge in New York City. J Clin Microbiol. 2020;58. doi:10.1128/JCM.00875-20.
6. Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical Characteristics of Covid-19 in New York City. N Engl J Med. 2020;382:2372–4. doi:10.1056/nejmc2010419.
7. Hughes S, Troise O, Donaldson H, Mughal N, Moore LSP. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect. 2020;26:1395–9. doi:10.1016/j.cmi.2020.06.025.
8. Ripa M, Galli L, Poli A, Oltolini C, Spagnuolo V, Mastrangelo A, et al. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect. 2020. doi:10.1016/j.cmi.2020.10.021.
9. Yu D, Ininbergs K, Hedman K, Giske CG, Strålin K, Özenci V. Low prevalence of bloodstream infection and high blood culture contamination rates in patients with COVID-19. PLoS One. 2020;15:e0242533. doi:10.1371/journal.pone.0242533.
10. Bhatt PJ, Shiau S, Brunetti L, Xie Y, Solanki K, Khalid S, et al. Risk Factors and Outcomes of Hospitalized Patients With Severe Coronavirus Disease 2019 (COVID-19) and Secondary Bloodstream Infections: A Multicenter Case-Control Study. Clin Infect Dis. 2020. doi:10.1093/cid/ciaa1748.
11. Zhang H, Zhang Y, Wu J, Li Y, Zhou X, Li X, et al. Risks and features of secondary infections in severe and critical ill COVID-19 patients. Emerg Microbes Infect. 2020;9:1958–64. doi:10.1080/22221751.2020.1812437.
12. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475–81. doi:10.1016/S2213-2600(20)30079-5.
13. Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146:110–8. doi:10.1016/j.jaci.2020.04.006.
14. Yu Y, Xu D, Fu S, Zhang J, Yang X, Xu L, et al. Patients with COVID-19 in 19 ICUs in Wuhan, China: A cross-sectional study. Crit Care. 2020;24. doi:10.1186/s13054-020-02939-x.
15. Cataldo MA, Tetaj N, Selleri M, Marchioni L, Capone A, Caraffa E, et al. Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming “collateral effect.” J Glob Antimicrob Resist. 2020;23:290–1. doi:10.1016/j.jgar.2020.10.004.
16. Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clinical Microbiology and Infection. 2013;19:501–9. doi:10.1111/1469-0691.12195.
17. Bhargava A, Sharma M, Riederer K, Fukushima EA, Szpunar SM, Saravolatz L. Risk Factors for In-hospital Mortality from Coronavirus Disease 2019 Infection Among Black Patients—An Urban Center Experience. Clin Infect Dis. 2020. doi:10.1093/cid/ciaa1468.
18. Pi-Sunyer FX, Becker DM, Bouchard C, Carleton RA, Colditz GA, Dietz WH, et al. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary. American Journal of Clinical Nutrition. 1998;68:899–917. doi:10.1093/ajcn/68.4.899.
19. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40:373–83. doi:10.1016/0021-9681(87)90171-8.
20. WHO. Clinical management of COVID-19. WHO, Geneva. 2020. https://www.who.int/publications/i/item/clinical-management-of-covid-19. Accessed 20 Dec 2020.
21. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron - Clinical Practice. 2012;120:c179–84. doi:10.1159/000339789.
22. Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of clinical criteria for sepsis for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA - J Am Med Assoc. 2016;315:762–74. doi:10.1001/jama.2016.0288.
23. Wu X, Liu L, Jiao J, Yang L, Zhu B, Li X. Characterisation of clinical, laboratory and imaging factors related to mild vs. severe covid-19 infection: a systematic review and meta-analysis. Annals of Medicine. 2020;52:334–44. doi:10.1080/07853890.2020.1802061.
24. Mohamed MS, Moulin TC, Schiöth HB. Sex differences in COVID-19: the role of androgens in disease severity and progression. Endocrine. 2021;71:3–8. doi:10.1007/s12020-020-02536-6.
25. Aziz M, Fatima R, Lee-Smith W, Assaly R. The association of low serum albumin level with severe COVID-19: A systematic review and meta-analysis. Critical Care. 2020;24. doi:10.1186/s13054-020-02995-3.
26. Wiedermann CJ. Hypoalbuminemia as Surrogate and Culprit of Infections. Int J Mol Sci. 2021;22. doi:10.3390/ijms22094496.
27. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708–20. doi:10.1056/nejmoa2002032.
28. Borakati A, Perera A, Johnson J, Sood T. Diagnostic accuracy of X-ray versus CT in COVID-19: A propensity-matched database study. BMJ Open. 2020;10:42946. doi:10.1136/bmjopen-2020-042946.
29. Giacobbe DR, Battaglini D, Ball L, Brunetti I, Bruzzone B, Codda G, et al. Bloodstream infections in critically ill patients with COVID-19. Eur J Clin Invest. 2020;50. doi:10.1111/eci.13319.